Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
10 mg of tirzepatide equals 50 units at a concentration of 20 mg/mL, or 100 units (a full 1 mL syringe) at a concentration of 10 mg/mL
Aly-Aly concluded that treating obesity and metabolic syndrome with GLP-1s is likely to have broad benefits that extend beyond just reducing BMI or reducing weight, while the drugs hold promise for addressing other diseases.
A landmark trial in the New England Journal of Medicine found that patients maintaining GLP-1 therapy preserved 80% of their weight loss two years into treatment, while those who stopped regained most losses
"Our results show that weight loss is achievable regardless of initial body mass index (BMI) and the amount of semaglutide used," said Gudbergsen
